is a commercial-stage dermatological cancer company, which engages in the provision of genomic information for physicians and patients.
Industry MedicalSpecialties
A.I.dvisor indicates that over the last year, CSTL has been loosely correlated with IMTH. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CSTL jumps, then IMTH could also see price increases.
Ticker / NAME | Correlation To CSTL | 1D Price Change % | ||
---|---|---|---|---|
CSTL | 100% | -2.99% | ||
IMTH - CSTL | 41% Loosely correlated | N/A | ||
VCYT - CSTL | 40% Loosely correlated | +3.37% | ||
FLGT - CSTL | 38% Loosely correlated | -3.86% | ||
RXST - CSTL | 37% Loosely correlated | -1.78% | ||
NVCR - CSTL | 35% Loosely correlated | +0.39% | ||
More |
Ticker / NAME | Correlation To CSTL | 1D Price Change % |
---|---|---|
CSTL | 100% | -2.99% |
Medical Specialties category (428 stocks) | 27% Poorly correlated | -1.28% |
Medical Specialties category (418 stocks) | 27% Poorly correlated | -1.48% |